APA (7th ed.) Citation

Josephina P. M. Vrouwe, Ingrid M. C. Kamerling, Michiel J. vanEsdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van derPluijm, . . . Susanne Osanto. (2021). An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer. Wiley.

Chicago Style (17th ed.) Citation

Josephina P. M. Vrouwe, Ingrid M. C. Kamerling, Michiel J. vanEsdonk, Josbert M. Metselaar, Frederik E. Stuurman, Gabri van derPluijm, Jacobus Burggraaf, and Susanne Osanto. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.

MLA (9th ed.) Citation

Josephina P. M. Vrouwe, et al. An Exploratory First‐in‐man Study to Investigate the Pharmacokinetics and Safety of Liposomal Dexamethasone at a 2‐ and 1‐week Interval in Patients with Metastatic Castration Resistant Prostate Cancer. Wiley, 2021.